Helmet Noninvasive Ventilation vs. High-flow Nasal Cannula in Moderate-to-severe Acute Hypoxemic Respiratory Failure

NACompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

October 13, 2020

Primary Completion Date

January 10, 2021

Study Completion Date

December 1, 2022

Conditions
Respiratory Failure With Hypoxia
Interventions
DEVICE

Noninvasive respiratory support

"In both arms, the treatment according to the assigned protocol will be continued until the patient requires endotracheal intubation or (in case of no intubation) up to ICU discharge.~Patients will have to undergo the allocated treatment within 1 hour from the moment of randomization and within 24 hours from admission in the intensive care unit"

Trial Locations (5)

Unknown

Policlinico di Sant'Orsola, Alma Mater Studiorum-Università di Bologna, Bologna

SS. Annunziata Hospital, Gabriele d'Annunzio University of Chieti-Pescara, Chieti

Azienda Ospedaliera-Universitaria Arcispedale Sant'Anna, University of Ferrara, Ferrara

Infermi Hospital, Rimini

Fondazione Policlinico Universitaro A. Gemelli IRCCS, Rome

All Listed Sponsors
collaborator

Università degli studi di Chieti

UNKNOWN

collaborator

Societa Italiana Anestesia Analgesia Rianimazione e Terapia Intensiva

OTHER

lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER

NCT04502576 - Helmet Noninvasive Ventilation vs. High-flow Nasal Cannula in Moderate-to-severe Acute Hypoxemic Respiratory Failure | Biotech Hunter | Biotech Hunter